Cito Capital Group, LLC Invitae Corp Transaction History

Cito Capital Group, LLC

  • $244 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$1.71 - $3.61 $51,300 - $108,300
-30,000 Reduced 60.0%
20,000 $37,000
Q3 2022

Nov 14, 2022
BUY
$1.9 - $8.63 $47,500 - $215,750
25,000 Added 100.0%
50,000 $123,000
Q2 2022

Aug 15, 2022
BUY
$2.13 - $9.01 $53,250 - $225,250
25,000 New
25,000 $61,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Cito Capital Group, LLC Portfolio

Follow Cito Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cito Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email